| 000 | 01800 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516141637.0 | ||
| 264 | 0 | _c20130904 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1096-9071 | ||
| 024 | 7 |
_a10.1002/jmv.23543 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUcciferri, Claudio | |
| 245 | 0 | 0 |
_aImproved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. _h[electronic resource] |
| 260 |
_bJournal of medical virology _cMay 2013 |
||
| 300 |
_a755-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBlood Chemical Analysis |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
| 650 | 0 | 4 | _aDarunavir |
| 650 | 0 | 4 |
_aDyslipidemias _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aFurans |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolome |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganophosphates _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProtease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aRitonavir _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aWhite People |
| 700 | 1 | _aFalasca, Katia | |
| 700 | 1 | _aVignale, Francesca | |
| 700 | 1 | _aDi Nicola, Marta | |
| 700 | 1 | _aPizzigallo, Eligio | |
| 700 | 1 | _aVecchiet, Jacopo | |
| 773 | 0 |
_tJournal of medical virology _gvol. 85 _gno. 5 _gp. 755-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmv.23543 _zAvailable from publisher's website |
| 999 |
_c22595660 _d22595660 |
||